Zacks Research Has Pessimistic Outlook of CLB Q2 Earnings

Core Laboratories Inc. (NYSE:CLB) – Research analysts at Zacks Research reduced their Q2 2027 earnings estimates for Core Laboratories in a report issued on Wednesday, June 17th. Zacks Research analyst Team now expects that the oil and gas company will post earnings of $0.27 per share for the quarter, down from their previous forecast of $0.28. The consensus estimate for Core Laboratories’ current full-year earnings is $0.56 per share. Zacks Research also issued estimates for Core Laboratories’ Q4 2027 earnings at $0.23 EPS and FY2027 earnings at $0.82 EPS.

Several other research analysts have also commented on the stock. Weiss Ratings lowered shares of Core Laboratories from a “hold (c)” rating to a “hold (c-)” rating in a research note on Monday, May 4th. Wall Street Zen lowered shares of Core Laboratories from a “hold” rating to a “sell” rating in a research note on Monday, May 25th. Three investment analysts have rated the stock with a Hold rating, According to MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $12.00.

Core Laboratories Stock Down 6.1%

NYSE CLB opened at $11.44 on Thursday. The company has a quick ratio of 1.50, a current ratio of 2.05 and a debt-to-equity ratio of 0.42. The company has a fifty day moving average of $14.64 and a two-hundred day moving average of $16.44. The firm has a market capitalization of $527.52 million, a price-to-earnings ratio of 17.60, a PEG ratio of 2.35 and a beta of 0.98. Core Laboratories has a 52 week low of $9.72 and a 52 week high of $20.36.

Core Laboratories (NYSE:CLB) last posted its quarterly earnings data on Wednesday, April 29th. The oil and gas company reported $0.06 EPS for the quarter, hitting the consensus estimate of $0.06. The company had revenue of $121.80 million during the quarter, compared to analyst estimates of $122.99 million. Core Laboratories had a net margin of 5.94% and a return on equity of 11.52%. Core Laboratories’s quarterly revenue was down 1.4% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.14 earnings per share. Core Laboratories has set its Q2 2026 guidance at 0.060-0.120 EPS.

Core Laboratories Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Monday, June 1st. Stockholders of record on Monday, May 11th were paid a dividend of $0.01 per share. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.3%. The ex-dividend date of this dividend was Monday, May 11th. Core Laboratories’s payout ratio is currently 6.15%.

Institutional Trading of Core Laboratories

Large investors have recently made changes to their positions in the stock. CWA Asset Management Group LLC purchased a new stake in shares of Core Laboratories during the fourth quarter valued at $9,978,000. UBS Group AG boosted its stake in shares of Core Laboratories by 32.9% during the fourth quarter. UBS Group AG now owns 412,515 shares of the oil and gas company’s stock valued at $6,613,000 after purchasing an additional 102,151 shares during the period. Pacific Ridge Capital Partners LLC purchased a new stake in shares of Core Laboratories during the third quarter valued at $525,000. Argos Wealth Advisors LLC purchased a new stake in shares of Core Laboratories during the fourth quarter valued at $258,000. Finally, CWM LLC boosted its stake in shares of Core Laboratories by 36.1% during the fourth quarter. CWM LLC now owns 2,516 shares of the oil and gas company’s stock valued at $40,000 after purchasing an additional 668 shares during the period. 97.81% of the stock is owned by hedge funds and other institutional investors.

About Core Laboratories

Core Laboratories N.V. is a global provider of proprietary and patented reservoir description and production enhancement services to the oil and gas industry. The company applies specialized expertise in core and fluid analysis, advanced petrophysical interpretation, and reservoir engineering to optimize hydrocarbon recovery. By integrating laboratory testing with field services and digital analytics, Core Laboratories delivers insights that help operators maximize production and extend the life of their assets.

The company’s portfolio spans two primary service lines: reservoir description and production enhancement.